Ann Hynes
Stock Analyst at Mizuho Securities
(4.66)
# 844
Out of 4,966 analysts
1137
Total ratings
59.9%
Success rate
8.6%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHC Encompass Health | Reiterated: Buy | $134 → $140 | $121.71 | +15.03% | 42 | Aug 11, 2026 | |
| MD Pediatrix Medical Group | Reiterated: Hold | $27 → $28 | $26.67 | +4.99% | 46 | Aug 11, 2026 | |
| CON Concentra Group Holdings Parent | Reiterated: Buy | $35 → $40 | $34.67 | +15.39% | 11 | Aug 10, 2026 | |
| CRL Charles River Laboratories International | Reiterated: Hold | $230 → $264 | $276.83 | -4.63% | 15 | Aug 10, 2026 | |
| LH Labcorp Holdings | Reiterated: Buy | $320 → $355 | $311.54 | +13.95% | 62 | Aug 10, 2026 | |
| THC Tenet Healthcare | Reiterated: Buy | $250 → $290 | $263.69 | +9.98% | 54 | Aug 10, 2026 | |
| ARDT Ardent Health | Reiterated: Buy | $12 → $13 | $10.98 | +18.40% | 8 | Aug 6, 2026 | |
| BTSG BrightSpring Health Services | Reiterated: Buy | $86 | $58.73 | +46.43% | 21 | Jul 31, 2026 | |
| FTRE Fortrea Holdings | Reiterated: Hold | $16 → $19 | $17.20 | +10.47% | 16 | Jul 31, 2026 | |
| IQV IQVIA Holdings | Reiterated: Buy | $230 → $275 | $258.17 | +6.52% | 53 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $260 | $235.02 | +10.63% | 65 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $525 → $475 | $426.94 | +11.26% | 64 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $665 | $587.52 | +13.19% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $470 → $493 | $379.09 | +30.05% | 57 | Jul 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $27 → $31 | $28.36 | +9.31% | 46 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $63 → $69 | $66.42 | +3.88% | 38 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $120 | $94.66 | +26.77% | 74 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $465 → $470 | $418.72 | +12.25% | 46 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $390 → $468 | $403.47 | +15.99% | 47 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 → $255 | $200.45 | +27.21% | 36 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $19 | $14.38 | +32.13% | 17 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 → $200 | $174.83 | +14.40% | 62 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $180 → $190 | $169.31 | +12.22% | 53 | Jun 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $330 → $340 | $280.76 | +21.10% | 38 | Jun 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $321.57 | n/a | 38 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $880.68 | n/a | 52 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $110 | $234.57 | n/a | 43 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $220 | $130.96 | n/a | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $569.19 | n/a | 1 | Sep 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $67.15 | n/a | 1 | Apr 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.6 | $2.89 | n/a | 16 | Jul 27, 2018 |
Encompass Health
Aug 11, 2026
Reiterated: Buy
Price Target: $134 → $140
Current: $121.71
Upside: +15.03%
Pediatrix Medical Group
Aug 11, 2026
Reiterated: Hold
Price Target: $27 → $28
Current: $26.67
Upside: +4.99%
Concentra Group Holdings Parent
Aug 10, 2026
Reiterated: Buy
Price Target: $35 → $40
Current: $34.67
Upside: +15.39%
Charles River Laboratories International
Aug 10, 2026
Reiterated: Hold
Price Target: $230 → $264
Current: $276.83
Upside: -4.63%
Labcorp Holdings
Aug 10, 2026
Reiterated: Buy
Price Target: $320 → $355
Current: $311.54
Upside: +13.95%
Tenet Healthcare
Aug 10, 2026
Reiterated: Buy
Price Target: $250 → $290
Current: $263.69
Upside: +9.98%
Ardent Health
Aug 6, 2026
Reiterated: Buy
Price Target: $12 → $13
Current: $10.98
Upside: +18.40%
BrightSpring Health Services
Jul 31, 2026
Reiterated: Buy
Price Target: $86
Current: $58.73
Upside: +46.43%
Fortrea Holdings
Jul 31, 2026
Reiterated: Hold
Price Target: $16 → $19
Current: $17.20
Upside: +10.47%
IQVIA Holdings
Jul 31, 2026
Reiterated: Buy
Price Target: $230 → $275
Current: $258.17
Upside: +6.52%
Jul 28, 2026
Reiterated: Buy
Price Target: $260
Current: $235.02
Upside: +10.63%
Jul 28, 2026
Reiterated: Buy
Price Target: $525 → $475
Current: $426.94
Upside: +11.26%
Jul 28, 2026
Reiterated: Buy
Price Target: $665
Current: $587.52
Upside: +13.19%
Jul 21, 2026
Reiterated: Buy
Price Target: $470 → $493
Current: $379.09
Upside: +30.05%
Jul 13, 2026
Reiterated: Hold
Price Target: $27 → $31
Current: $28.36
Upside: +9.31%
Jul 13, 2026
Reiterated: Hold
Price Target: $63 → $69
Current: $66.42
Upside: +3.88%
Jul 13, 2026
Reiterated: Buy
Price Target: $115 → $120
Current: $94.66
Upside: +26.77%
Jul 13, 2026
Reiterated: Buy
Price Target: $465 → $470
Current: $418.72
Upside: +12.25%
Jul 13, 2026
Reiterated: Buy
Price Target: $390 → $468
Current: $403.47
Upside: +15.99%
Jul 13, 2026
Reiterated: Buy
Price Target: $215 → $255
Current: $200.45
Upside: +27.21%
Jul 13, 2026
Reiterated: Buy
Price Target: $17 → $19
Current: $14.38
Upside: +32.13%
Jul 13, 2026
Reiterated: Buy
Price Target: $230 → $200
Current: $174.83
Upside: +14.40%
Jun 26, 2026
Reiterated: Buy
Price Target: $180 → $190
Current: $169.31
Upside: +12.22%
Jun 8, 2026
Reiterated: Buy
Price Target: $330 → $340
Current: $280.76
Upside: +21.10%
Mar 7, 2025
Reiterated: Buy
Price Target: n/a
Current: $321.57
Upside: n/a
Nov 6, 2024
Reiterated: Hold
Price Target: n/a
Current: $880.68
Upside: n/a
Nov 4, 2024
Rated: Hold
Price Target: $110
Current: $234.57
Upside: n/a
Nov 8, 2022
Reiterated: Hold
Price Target: $220
Current: $130.96
Upside: n/a
Sep 12, 2022
Reiterated: Buy
Price Target: n/a
Current: $569.19
Upside: n/a
Apr 11, 2022
Reiterated: Buy
Price Target: n/a
Current: $67.15
Upside: n/a
Jul 27, 2018
Reiterated: Hold
Price Target: $4.5 → $3.6
Current: $2.89
Upside: n/a